Larvol Delta - Assessing-breakthrough-infections-Covishield-late-schedule-versus-Covaxin--A-prospective-comparative-analysis-in-the-general-population

Vaxzevria (ChAdOx1-S recombinant) - University of Oxford, Emergent Biosolutions, Jenner Institute, Barinthus Bio, AstraZeneca

Covaxin (BBV152 COVID Vaccine) - Bharat Biotech, Indian Council of Medical Research, Ocugen

http://www.ncbi.nlm.nih.gov/pubmed/40726698

Anamika Soni; Anuradha Nadda; Kapil Goel; Neha Kapoor; Nikhil Govil; Nikita Sharma; Nishu Gupta; Rahul Gupta; Ritu Attri; Sahil Sharma; Taranjot Kaur; Viyusha T Viswanathan

Jul 29, 2025